This content is generated by AI. You can give feedback on it in the Inderes forum.
Translation: Original published in Finnish on 11/20/2026 at 08:00 am EET
| Estimates | Q3'25 | Q3'26 | Q3'26e | Difference (%) |
| MEUR / EUR | Comparison | Actualized | Inderes | Act. vs. Inderes |
| Revenue | 53.8 | 73.6 | 68.2 | 8 % |
| EBITA (adj.) | 4.3 | 8.4 | 6.5 | |
| EBIT | 2.1 | 6.4 | 4.5 | 42 % |
| PTP | 1.5 | 6.0 | 4.0 | 50 % |
| EPS (rep.) | - | 0.16 | 0.12 | 34 % |
| Revenue growth-% | - | 36.7 % | 26.8 % | 10 pp |
| EBITA (adj.) | 8.0 % | 11.4 % | 9.5 % | 1.9 pp |
| Source: Inderes |
Auroora's Q3 figures clearly exceeded our estimates, particularly as organic growth remained very strong and profitability improved across all segments. Returns on capital are already strong, and new capital for investment is being generated at an accelerating pace thanks to strong cash flow. Thus, the compounder's model is currently working exactly as it should. Against this backdrop, we believe the valuation remains attractive. We raise our target price to EUR 12.0 (was EUR 11.5) and reiterate our Accumulate recommendation.
Auroora's Q3 revenue grew by 37% to 73.6 MEUR, clearly exceeding our forecast of 27% growth. The beat was driven by stronger-than-expected organic growth (21%), while the impact of acquisitions (16%) was in line with our expectations. As expected, organic growth was again strong in the Electrification and Automation segment (39%), where data center investments, among other things, are accelerating electrification. Growth was broad-based and did not rely on individual projects. Auroora’s EBITA nearly doubled to 8.4 MEUR (Q3'25: 4.3 MEUR) and alsoexceeded our 6.5 MEUR estimate. The split between organic and inorganic growth in earnings was roughly the same as in revenue.
Operating cash flow was also strong (7.3 MEUR including leases), and net debt/EBITDA fell to 0.5x at the end of the quarter (Q2’26: 0.7x). Return on capital (ROCE) has already risen above 20%, so in our view, the compounder model is currently working across all key metrics.
Auroora does not provide guidance, so the most important metric for the near-term outlook is the order book. It was 167 MEUR, or ~25% higher than a year ago, and practically on par with Q2. Demand has thus remained strong, but we consider it likely that the organic growth rate will slow down next year against very strong comparison periods.
We again clearly raise our estimates (adj. EBIT 2027e-2028e 17%), driven by the Q3 figures, slightly higher organic growth estimates, and the acquisitions the company completed after the review period. The exact valuation multiples for these are not known, but according to the company, the multiples were in line with its investment criteria (EV/EBITA 4x-8x). The EBITA margin for all targets is also clearly in the double digits, although the earnings level of the Labko acquisition will likely face some pressure immediately following the deal, as it is carved out from a larger entity and the company must invest, e.g., in a new ERP system. In the Coating Source and BRIX Facades acquisitions, the company bought a 70% stake, so part of their earnings will belong to minority shareholders going forward. As a result, our EPS estimates rise less than our operating estimates (going forward, a slightly larger share of earnings will go to minority interests). Auroora has a call option for the remaining 30%.
Auroora's multiples for the current year are somewhat demanding, but investors should keep their sights set on 2027, when the completed acquisitions will be reflected in the figures. This puts the adjusted P/E at 16x and the adjusted EV/EBIT at 12.5x. We consider the levels to be moderate, considering the company's organic and inorganic growth outlook. Our DCF model value rose to EUR 10.5, which is roughly in line with the current share price. Thus, we believe the share does not price in future value-creating acquisitions on top of the current business. Valuation risk has increased following the post-listing share price rise, but considering the value creation opportunities from acquisitions and the organic performance of the business, we still find the risk/reward attractive.